Journal of the American Academy of Dermatology
Post-market surveillance data demonstrate high mortality associated with enfortumab vedotin skin toxicity, not worsened by immune checkpoint inhibitors or corticosteroids.
Mackenzie M Kilton, Erin X Wei, Corey J Georgeson, Jesse P Hirner
Published: 202510.1016/j.jaad.2025.10.134
No abstract available for this study.